← Home / Cue Biopharma, Inc. (CUE)
Stock Analysis
Cue Biopharma, Inc. (CUE)
CUE
CUE · Market data
26.63 -0.37%
52W Range Position
70%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-06-18 17:32 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 35.73. Holding above 23.45 keeps the current thesis intact.
⚖️
Fundamentals
Strong / Negative
Price Structure
Constructive
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
23.45
Break Above
Confirmation improves above resistance.
35.73
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 23.45
What's Driving CUE?
📈 Technical recovery is improving
Momentum is Neutral. Watch 35.73 for confirmation and 23.45 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 23.45
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression
State
Forming
Breakout Watch
Downtrend line not broken yet · score 0
Compression
91%
RSI(14)
53.1
How to read this setup
The nearest decision zone is framed by support around 23.77 and resistance near 29.39. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
CUE · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Strong
Profitability
Negative
Cash Flow
Mixed
Balance Sheet
Manageable
💵 Revenue
5.69M
↗ Strong
📈 Net Income
-5.18M
↘ Negative
🧮 EPS (Basic)
-1.08
↘ Negative
Cue Biopharma, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.